Subclinic atherosclerosis and cardiovascular risk factors in HIV-infected children: PERI study

Coronary Artery Disease

Volumn 19, Issue 3, 2008, Pages 167-172

  Giuliano, Isabela De C B ^a,b   De Freitas, Sergio F T ^c   De Souza, Maria ^b   Caramelli, Bruno ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL INFANTIL JOANA DE GUSMÃO   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Adolescent; AIDS; Atherosclerosis; C reactive protein; Cardiovascular risk factors; Child; Glucose metabolism; Intima media thickness; Lipids

Indexed keywords

C REACTIVE PROTEIN; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; STAVUDINE; TRIACYLGLYCEROL;

ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPID BLOOD LEVEL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TACHYPNEA;

ADOLESCENT; C-REACTIVE PROTEIN; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; FEMALE; HIV INFECTIONS; HUMANS; MALE; REVERSE TRANSCRIPTASE INHIBITORS; STAVUDINE; TUNICA INTIMA; TUNICA MEDIA;

EID: 42349098851     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3282f6dffb     Document Type: Article

References (37)

1. Miranda AE, Soares RA, Prado BC, Monteiro RB, Figueiredo NC. Mother to child transmission of HIV in Vitoria, Brazil: factors associated with lack of HIV prevention. AIDS Care 2005; 17:721-728.
2. Lipshultz SE, Easley KA, Orav EJ, Kaplan S, Starc TJ, Bricker JT, et al. Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group. Circulation 1998; 97:1246-1256.
3. Lipshultz SE, Easley KA, Orav EJ, Kaplan S, Starc TJ, Bricker JT, et al. Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study. Lancet 2002; 360:368-373.
4. Selik RM, Lindegren ML. Changes in deaths reported with human immunodeficiency virus infection among United States children less than thirteen years old, 1987 through 1999. Pediatr Infect Dis J 2003; 22:635-641.
5. Litwin M, Wuhl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, et al. Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 2005; 16:1494-1500.
6. Liuba P, Persson J, Luoma J, Yla-Herttuala S, Pesonen E. Acute infections in children are accompanied by oxidative modification of LDL and decrease of HDL cholesterol, and are followed by thickening of carotid intima-media. Eur Heart J 2003; 24:515-521.
7. Maggi P, Perilli F, Lillo A, Carito V, Epifani G, Bellacosa C, et al. An ultrasound-based comparative study on carotid plaques in HIV-positive patients vs. atherosclerotic and arteritis patients: atherosclerotic or inflammatory lesions? Coron Artery Dis 2007; 18:23-29.
8. Bonnet D, Aggoun Y, Szezepanski I, Bellal N, Blanche S. Arterial stiffness and endothelial dysfunction in HIV-infected children. AIDS 2004; 18:1037-1041.
9. Charakida M, Donald AE, Green H, Storry C, Clapson M, Caslake M, et al. Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy. Circulation 2005; 112:103-109.
10. Ribeiro RQ, Lotufo PA, Lamounier JA, Oliveira RG, Soares JF, Botter DA. Additional cardiovascular risk factors associated with excess weight in children and adolescents: the Belo Horizonte heart study. Arq Bras Cardiol 2006; 86:408-418.
11. Trumbo P, Schlicker S, Yates AA, Poos M. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc 2002; 102:1621-1630.
12. Tudor-Locke C, Williams JE, Reis JP, Pluto D. Utility of pedometers for assessing physical activity: construct validity. Sports Med 2004; 34:281-291.
13. Wells JC, Fewtrell MS. Measuring body composition14. Arch Dis Child 2006; 91:612-617.
14. Fernandez JR, Redden DT, Pietrobelli A, Allison DB. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 2004; 145:439-444.
15. Dzwonek AB, Lawson MS, Cole TJ, Novelli V. Body fat changes and lipodystrophy in HIV-infected children: impact of highly active antiretroviral therapy11. J Acquir Immune Defic Syndr 2006; 43:121-123.
16. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114 (2 Suppl 4th Report):555-576.
17. Strong WB, Downs TD, Liebman J, Liebowitz R. The normal adolescent electrocardiogram. Am Heart J 1972; 83:115-128.
18. Daniels SR, Meyer RA, Liang YC, Bove KE. Echocardiographically determined left ventricular mass index in normal children, adolescents and young adults. J Am Coll Cardiol 1988; 12:703-708.
19. Gutgesell HP, Paquet M, Duff DF, McNamara DG. Evaluation of left ventricular size and function by echocardiography. Results in normal children. Circulation 1977; 56:457-462.
20. Martin-Duran R, Larman M, Trugeda A, Vazquez de Prada JA, Ruano J, Torres A, et al. Comparison of Doppler-determined elevated pulmonary arterial pressure with pressure measured at cardiac catheterization. Am J Cardiol 1986; 57:859-863.
21. Sheil ML, Jenkins O, Sholler GF. Echocardiographic assessment of aortic root dimensions in normal children based on measurement of a new ratio of aortic size independent of growth. Am J Cardiol 1995; 75:711-715.
22. Spirito P, Maron BJ, Bonow RO. Noninvasive assessment of left ventricular diastolic function: comparative analysis of Doppler echocardiographic and radionuclide angiographic techniques. J Am Coll Cardiol 1986; 7:518-526.
23. ABEP. Critério de classificação econômica Brasil. ABEP 2006 May 5 [cited 2004 May 5]; Available from: URL: http://www.anep.org.br
24. Riafai N, Warnick GR, Dominiczack MH. Handbook of lipoprotein testing. Washington: American Association for Clinical Chemistry; 1997.
25. Srinivasan V, Pamula VK, Fair RB. An integrated digital microfluidic lab-ona-chip for clinical diagnostics on human physiological fluids. Lab Chip 2004; 4:310-315.
26. Nathan DM, Singer DE, Hurxthal K, Goodson JD. The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 1984; 310:341-346.
27. Cazzolato G, Prakasch G, Green S, Kostner GM. The determination of lipoprotein Lp(a) by rate and endpoint nephelometry. Clin Chim Acta 1983; 135:203-208.
28. Jourdan C, Wuhl E, Litwin M, Fahr K, Trelewicz J, Jobs K, et al. Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens 2005; 23:1707-1715.
29. Dario Noleto. Critérios de definição de casos de SIDA em adultos e crianças. MInistério da Saúde 2004 May 5 [cited 2005 Jan 23]; Available from: URL: http://www.aids.gov.br/data/documents/ storedDocuments/%7BB8EF5DAF-23AE-4891-AD36-1903553A3174%7D/%7B2A9F7D1C-093E- 4A04-8380-4ED432964A5%7D/criterios.pdf
30. Rickerts V, Brodt H, Staszewski S, Stille W. Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study. Eur J Med Res 2000; 5:329-333.
31. Caramelli B, de Bernoche CY, Sartori AM, Sposito AC, Santos RD, Monachini MC, et al. Hyperlipidemia related to the use of HIV-protease inhibitors: natural history and results of treatment with fenofibrate. Braz J Infect Dis 2001; 5:332-338.
32. Hajjar LA, Calderaro D, Yu PC, Giuliano I, Lima EM, Barbaro G, et al. Manifestações cardiovasculares em pacientes com infecção pelo vírus da imunodeficiência humana. Arq Bras Cardiol 2005; 85:363-377.
33. Rose H, Woolley I, Hoy J, Dart A, Bryant B, Mijch A, et al. HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment. Metabolism 2006; 55:90-95.
34. Sposito AC, Caramelli B, Sartori AM, JA FR. The lipoprotein profile in HIV infected patients. Braz J Infect Dis 1997; 1:275-283.
35. Jansen CA, Piriou E, Bronke C, Vingerhoed J, Kostense S, van BD, et al. Characterization of virus-specific CD8( + ) effector T cells in the course of HIV-1 infection: longitudinal analyses in slow and rapid progressors. Clin Immunol 2004; 113:299-309.
36. Kivimaki M, Smith GD, Juonala M, Ferrie JE, Keltikangas-Jarvinen L, Elovainio M, et al. Socioeconomic position in childhood and adult cardiovascular risk factors, vascular structure, and function: cardiovascular risk in young Finns study. Heart 2006; 92:474-480.
37. Jarvisalo MJ, Harmoinen A, Hakanen M, Paakkunainen U, Viikari J, Hartiala J, et al. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol 2002; 22:1323-1328.